Empetus 100 mg (Ritonavir)
Empetus 100 mg (Ritonavir) | Variation | Price | Price / Unit | Quantity | Add To Cart |
|---|---|---|---|---|
| 30 Tablet/s | $105.00 | $3.5/ Piece | ||
| 60 Tablet/s | $204.00 | $3.4/ Piece | ||
| 90 Tablet/s | $297.00 | $3.3/ Piece | ||
| Active Ingredient (Generic Name): | Ritonavir |
| Manufacturer: | Emcure Pharmaceuticals Ltd. |
| Packaging: | 30 Tablets in bottle |
| Strength: | 100 MG |
| Delivery Time: | 6 To 15 days |
| SKU: | Empetus 100 mg (Ritonavir) |
Product details
| Quantity Value |
30 Tablet/s ,60 Tablet/s ,90 Tablet/s |
|---|
Description
Customer Reviews
Rated 0 out of 5
0 reviews
Rated 5 out of 5
0
Rated 4 out of 5
0
Rated 3 out of 5
0
Rated 2 out of 5
0
Rated 1 out of 5
0
Be the first to review “Empetus 100 mg (Ritonavir)” Cancel reply
Related Products
Select options
This product has multiple variants. The options may be chosen on the product page
Imiquad Cream (Imiquimod)
$165.00 – $450.00Price range: $165.00 through $450.00
Select options
This product has multiple variants. The options may be chosen on the product page
Afatinib 20 mg
$98.00 – $278.00Price range: $98.00 through $278.00
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page
Azacitidine 100 mg Injection
$250.00 – $690.00Price range: $250.00 through $690.00
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page
Select options
This product has multiple variants. The options may be chosen on the product page

Reviews
Clear filtersThere are no reviews yet.